Use of complementary and alternative medicine (CAM) treatments by parents of children with autism spectrum disorders

Research in Autism Spectrum Disorders

Volumn 4, Issue 2, 2010, Pages 249-259

  Christon, Lillian M ^a   Mackintosh, Virginia H ^b   Myers, Barbara J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF MARY WASHINGTON   (United States)

Author keywords

Alternative; Autism; Children; Complementary; Medicine; Parent report; Treatments

Indexed keywords

OXYGEN; SECRETIN; VITAMIN;

ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; AUTISM; CHELATION THERAPY; CHILD; CONTROLLED STUDY; CRANIOSACRAL THERAPY; DIET THERAPY; DRUG COST; EXPECTATION; FEMALE; HEALTH CARE COST; HUMAN; HYPERBARIC OXYGEN; INTERNET; MAGNETOTHERAPY; MAJOR CLINICAL STUDY; MALE; MUSIC THERAPY; PARENTAL ATTITUDE; PATIENT DECISION MAKING; PET THERAPY; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT WITHDRAWAL;

EID: 73649123498     PISSN: 17509467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rasd.2009.09.013     Document Type: Article

References (42)

1. Autism Research Institute. Autism Research Institute/Defeat Autism Now (2009). http://www.autism.com/ Retrieved August 27, 2009 from: http://www.autism.com/
2. Christison G.W., and Ivany K. Elimination diets in Autism Spectrum Disorders: Any wheat amidst the chaff?. Developmental and Behavioral Pediatrics 27 (2006) S162-S171
3. Coplan J., Souders M.C., Mulberg A.E., Belchic J.K., Wray J., Jawad A.F., et al. Children with autistic spectrum disorders. II. Parents are unable to distinguish secretin from placebo under double-blind conditions. Archives of Diseases of Children (2003) 737-739
4. Dunn-Geier J., Ho H.H., Auersberg E., Doyle D., Eaves L., Matsuba C., et al. Effect of secretin on children with autism: A randomized controlled trial. Developmental Medicine and Child Neurology 42 (2000) 796-802
5. Esch B.E., and Carr J.E. Secretin as a treatment for autism: A review of the evidence. Journal of Autism and Developmental Disorders 34 (2004) 543-556
6. Fraley R.C. How to conduct behavioral research over the internet: A beginner's guide to HTML and CGI/Perl (2004), The Guilford Press, New York, NY
7. Friedman L.M., Furberg C.D., and DeMets D.L. Fundamentals of Clinical Trials. 3rd edition (1998), Springer Science, New York, NY
8. Goin-Kochel R.P., Myers B.J., and Mackintosh V.H. Parental reports on the use of treatments and therapies for children with autism spectrum disorders. Research in Autism Spectrum Disorders 1 (2007) 195-209
9. Goin-Kochel R.P., Mackintosh V.H., and Myers B.J. Parental reports on the efficacy of treatments and therapies for their children with autism spectrum disorders. Research in Autism Spectrum Disorders 3 (2009) 528-537
10. Gosling S.D., Vazire S., Srivastava S., and John O. Should we trust web-based studies? A comparative analysis of six preconceptions about internet questionnaires. American Psychologist 59 (2004) 93-104
11. Granello D.H., and Wheaton J.E. Online data collection: Strategies for research. Journal of Counseling and Development 82 (2004) 387-393
12. Green V.A., Pituch K.A., Itchon J., Choi A., O'Reilly M., and Sigafoos J. Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities 27 (2006) 70-84
13. Hanson E., Kalish L.A., Bunce E., Curtis C., McDaniel S., Ware J., et al. Use of complementary and alternative medicine among children diagnosed with autism spectrum disorders. Journal of Autism and Developmental Disorders 37 (2007) 628-636
14. Harrington J.W., Rosen L., and Garnecho A. Parental perceptions and use of complementary and alternative medicine practices for children with Autistic Spectrum Disorders in private practice. Developmental and Behavioral Pediatrics 27 (2006) S156-S161
15. Herbert J.D., Sharp I.R., and Gaudiano B.A. Separating fact from fiction in the etiology and treatment of autism: A scientific review of the evidence. The Scientific Review of Mental Health Practice 1 (2002) 23-43
16. Hyman S.L., and Levy S.E. Introduction: Novel therapies in developmental disabilities-Hope, reason, and evidence. Mental Retardation and Developmental Disabilities 11 (2005) 107-109
17. Jacobson J.W., Foxx R.M., and Mulick J.A. Facilitated communication: The ultimate fad treatment. In: Jacobson J.W., Foxx R.M., and Mulick J.A. (Eds). Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (2005), Lawrence Erlbaum Associates, Inc., Mawah, NJ 363-383
18. Johnson C.P., Myers S.M., and the Council on Children with Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics 120 (2007) 1183-1215
19. Kemper K.J., and O'Connor K.G. Pediatricians' recommendations for complementary and alternative (CAM) therapies. Ambulatory Pediatrics 4 (2004) 482-487
20. Levy A.G., and Hershey J.C. Distorting the probability of treatment success to justify treatment decisions. Organizational Behavior and Human Decision Processes 101 (2006) 52-58
21. Levy A.G., and Hershey J.C. Value-induced bias in medical decision making. Medical Decision Making 28 (2008) 269-276
22. Levy S.E., and Hyman S.L. Alternative/complementary approaches to treatment of children with autistic spectrum disorders. Infants and Young Children 14 (2002) 33-42
23. Levy S.E., and Hyman S.L. Novel treatments for autistic spectrum disorders. Mental Retardation and Developmental Disabilities 11 (2005) 131-142
24. Levy S.E., and Hyman S.L. Complementary and alternative medicine treatments for children with autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America 17 (2008) 803-820
25. Levy S.E., Mandell D.S., Merhar S., Ittenbach R.F., and Pinto-Martin J.A. Use of complementary and alternative medicine among children recently diagnosed with autistic spectrum disorder. Developmental and Behavioral Pediatrics 24 (2003) 418-423
26. Liptak G.S., Orlando M., Yingling J.T., Theurer-Kaufman K.L., Malay D.P., Tompkins L.A., et al. Satisfaction with primary health care received by families of children with developmental disabilities. Journal of Pediatric Health Care 20 (2006) 245-252
27. Lord C., Wagner A., Rogers S., Szatmari P., Aman M., Charman T., et al. Challenges in evaluating psychosocial interventions for autistic spectrum disorders. Journal of Autism and Developmental Disorders 35 (2005) 695-708
28. Mackintosh V.H., Goin-Kochel R.P., and Myers B.J. Sources of information and support used by parents of children with autism spectrum disorders. Journal on Developmental Disabilities 12 (2005) 41-51
29. Mostert M.P. Facilitated communication since 1995: A review of published studies. Journal of Autism and Developmental Disorders 31 (2001) 287-313
30. Mudford O.C., Cross B.A., Breen S., Cullen C., Reeves D., Gould J., et al. Auditory integration training for children with autism: No behavioral benefits detected. American Journal on Mental Retardation 105 (2000) 118-129
31. Newsom C., and Hovanitz C.A. The nature and value of empirically validated interventions. In: Jacobson J.W., Foxx R.M., and Mulick J.A. (Eds). Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (2005), Lawrence Erlbaum Associates, Inc., Mawah, NJ 31-44
32. Pavone L., and Ruggieri M. The problem of alternative therapies in autism. In: Coleman M. (Ed). The neurology of autism (2005), Oxford University Press, Oxford 172-200
33. Preckel F., and Thiemann H. Online- versus paper-pencil-version of a high potential intelligence test. Swiss Journal of Psychology 62 (2003) 131-138
34. Rossignol D.A., Rossignol L.W., Smith S., Schneider C., Logerquist S., Usman A., et al. Hyperbaric treatment for children with autism: A multicenter, randomized, double-blind, controlled trial. BMC Pediatrics 9 (2009) 21
35. Sandler A. Placebo effects in developmental disabilities: Implications for research and practice. Mental Retardation and Developmental Disabilities 11 (2005) 164-170
36. Sandler A.D., Sutton K.A., DeWeese J., Girardi M.A., Sheppard V., and Bodfish J.W. Lack of benefit of synthetic human secretin in the treatment of autism and pervasive developmental disabilities. New England Journal of Medicine 341 (1999) 1801-1806
37. Shiv B., Carmon Z., and Ariely D. Placebo effects of marketing actions: Consumers may get what they pay for. Journal of Marketing Research 42 (2005) 383-393
38. Smith T. The appeal of unvalidated treatments. In: Jacobson J.W., Foxx R.M., and Mulick J.A. (Eds). Controversial therapies for developmental disabilities: Fad, fashion, and science in professional practice (2005), Lawrence Erlbaum Associates, Inc., Mawah, NJ 45-57
39. Soden S.E., Lowry J.A., Garrison C.B., and Wasserman G.S. 24-hour provoked urine excretion test for heavy metals in children with autism and typically developing controls, a pilot study. Clinical Toxicology 45 (2007) 476-481
40. Sturmey P. Secretin is an ineffective treatment for pervasive developmental disabilities: A review of 15 double-blind randomized controlled trials. Research in Developmental Disabilities 26 (2005) 87-97
41. Williamson C. Dolphin assisted therapy: Can swimming with dolphins be a suitable treatment?. Developmental Medicine and Child Neurology 50 (2008) 477-1477
42. Wong H.H.L., and Smith R.G. Patterns of complementary and alternative medical therapy use in children diagnosed with autism spectrum disorders. Journal of Autism and Developmental Disorders 36 (2006) 901-909